Vasculitis & polymyalgia rheumatica

Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual

Arthritis Care Res (Hoboken)Published Cohort study

Authors' conclusion

More than 60% of patients with GPA/MPA achieved prolonged remission, which was associated with better long-term outcomes. In contrast, prolonged LDAS correlated with increased damage accrual and was not a sufficient treatment target.

Study context

Population
Patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) followed for ≥5 years in 2 centres (128 GPA, 39 MPA; mean ± SD age 51.0 ± 16.7 years)
Participants
167 patients
Exposure
Levels of disease activity and 5-year damage accrual
  • Complete remissionn = 10
  • Clinical remission off therapy (CROffT)n = 6
  • Clinical remission on therapy (CROnT)n = 89
  • Low disease activity state (LDAS)n = 42
  • Never LDASn = 20
Outcome
Prevalence of prolonged (≥2 consecutive years) remission or LDAS, and damage accrual (VDI)
Follow-up
5 years
Methodological details2 centres, ≥5 years follow-up, multivariate analysis
  • 2 centres
  • ≥5 years follow-up
  • Multivariate analysis

Main finding

As reported in the abstract

Prolonged remission/LDAS achieved during 5-year follow-up

Observational data: associations, not effects.

Further findings

Mean

OutcomeNo prolonged remissionProlonged remissionP value
VDI score at 5 years, by prolonged remission3.7 (SD 2.0)2.2 (SD 1.9)P < 0.0001

Vasculitis Damage Index (VDI) score at 5 years, by prolonged remission

VDI at 5 years progressively worsened with increasing levels of disease activity targets (complete remission, CROffT, CROnT, LDAS)

Negative predictors of prolonged remission (multivariate)

Baseline ear, nose and throat involvement
P = 0.006
Baseline lung involvement
P = 0.047

Original publication

Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual. Arthritis Care Res (Hoboken). Published 21 December 2022. doi:10.1002/acr.24958

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.